Total Valuation
Vicore Pharma Holding AB Sponsored ADR has a market cap or net worth of $263.57M. The enterprise value is ―.
Market Cap$263.57M
Enterprise Value―
Share Statistics
Vicore Pharma Holding AB Sponsored ADR has 28,152,560 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,152,560
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vicore Pharma Holding AB Sponsored ADR’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -41.31%.
Return on Equity (ROE)-0.44
Return on Assets (ROA)-0.39
Return on Invested Capital (ROIC)-41.31%
Return on Capital Employed (ROCE)-0.41
Revenue Per Employee103.16K
Profits Per Employee-12.23M
Employee Count37
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Vicore Pharma Holding AB Sponsored ADR is ―. Vicore Pharma Holding AB Sponsored ADR’s PEG ratio is -0.12.
PE Ratio―
PS Ratio941.48
PB Ratio3.28
Price to Fair Value3.28
Price to FCF-9.56
Price to Operating Cash Flow-118.01
PEG Ratio-0.12
Income Statement
In the last 12 months, Vicore Pharma Holding AB Sponsored ADR had revenue of 3.82M and earned -477.47M in profits. Earnings per share was -19.90.
Revenue3.82M
Gross Profit3.82M
Operating Income-454.44M
Pretax Income-477.47M
Net Income-477.47M
EBITDA-477.41M
Earnings Per Share (EPS)-19.90
Cash Flow
In the last 12 months, operating cash flow was -225.86M and capital expenditures 0.00, giving a free cash flow of -225.86M billion.
Operating Cash Flow-225.86M
Free Cash Flow-225.86M
Free Cash Flow per Share-8.02
Dividends & Yields
Vicore Pharma Holding AB Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.54
52-Week Price Change-29.36%
50-Day Moving Average11.26
200-Day Moving Average―
Relative Strength Index (RSI)29.10
Average Volume (3m)21.21K
Important Dates
Vicore Pharma Holding AB Sponsored ADR upcoming earnings date is Nov 5, 2026, TBA (Confirmed).
Last Earnings DateAug 21, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Vicore Pharma Holding AB Sponsored ADR as a current ratio of 10.28, with Debt / Equity ratio of 0.00%
Current Ratio10.28
Quick Ratio10.28
Debt to Market Cap0.00
Net Debt to EBITDA1.21
Interest Coverage Ratio-7.57K
Taxes
In the past 12 months, Vicore Pharma Holding AB Sponsored ADR has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Vicore Pharma Holding AB Sponsored ADR EV to EBITDA ratio is -6.32, with an EV/FCF ratio of -8.03.
EV to Sales790.02
EV to EBITDA-6.32
EV to Free Cash Flow-8.03
EV to Operating Cash Flow-8.03
Balance Sheet
Vicore Pharma Holding AB Sponsored ADR has $93.41M in cash and marketable securities with $0.00 in debt, giving a net cash position of $93.41M billion.
Cash & Marketable Securities$93.41M
Total Debt$0.00
Net Cash$93.41M
Net Cash Per Share$3.32
Tangible Book Value Per Share$45.67
Margins
Gross margin is 100.00%, with operating margin of -11905.82%, and net profit margin of -12509.14%.
Gross Margin100.00%
Operating Margin-11905.82%
Pretax Margin-12509.14%
Net Profit Margin-12509.14%
EBITDA Margin-12507.57%
EBIT Margin-12507.57%
Analyst Forecast
The average price target for Vicore Pharma Holding AB Sponsored ADR is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-42.16%
EPS Growth Forecast-11.59%